Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)

Company Overview - Regeneron Pharmaceuticals, Inc. is a well-established biotech company based in Tarrytown, NY, founded in 1988 and has experienced significant growth since reaching an inflection point in 2011 [1] Investment Philosophy - The company emphasizes the importance of patient investing through good and bad times, highlighting the joy of compounding and the value of dividend reinvesting as key to wealth creation [1] Investment Strategy - The investment approach combines steady accumulation of high-quality assets with high-risk/high-reward opportunities, underappreciated turnaround plays, and transformative technologies [1]